Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dr Paolo Gatti AB
AB
Active
Org 5593589574
Drejargatan 6
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 731K
-5% vs 2023
EBITDA margin
61.5%
+107% vs 2023
Equity ratio
79.2%
Financial strength
Net profit 2024
SEK 332K
+140% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 731K
-5%
EBITDA
SEK 450K
+107%
Net profit
SEK 332K
+140%
Total assets
SEK 455K
+71%
Equity
SEK 361K
+121%
Employees
1
—
Company information
Legal name
Dr Paolo Gatti AB
Org number
5593589574
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7 januari 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten erbjuder konsultationer inom elektrokardiogram.
Contact
Address
Drejargatan 6
Email
88paolo.gatti@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
500
773
731
Staff expenses
−172
−266
−83
EBITDA
215
217
450
Depreciation & amort.
−16
−28
−28
EBIT
199
189
422
Net financials
0
−0
−1
Profit before tax
199
189
421
Tax
−41
−51
−89
Net profit
158
138
332
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
226
267
455
Equity
183
163
361
Long-term debt
—
—
—
Short-term debt
43
103
95
Total debt
43
103
95
Financial ratios
5-year trend
EBITDA margin
61.5%
This company
15.8%
Market median
+289% vs market
2022
2024
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
2022
2024
Return on equity
92.2%
This company
18.4%
Market median
+401% vs market
2022
2024
Net profit margin
45.4%
This company
8.1%
Market median
+460% vs market
2022
2024
Asset turnover
1.61×
This company
1.12×
Market median
+44% vs market
2022
2024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-07 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AK
Anna Kristina Lovisa Johansson
Deputy Board Member
2025
PG
Paolo Gatti
Board of Directors
2022
Former (1)
GS
Gianluigi Savarese
Deputy Board Member
2022 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dr Paolo Gatti AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anna Kristina Lovisa Johansson
Deputy Board Member
0 companies
Paolo Gatti
Board of Directors
0 companies
Gianluigi Savarese
Deputy Board Member
0 companies